Should we lose hope in adjuvant therapy for neuroendocrine tumors?—In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. Issue 3 (10th June 2020) - Lamberti, Giuseppe; Manuzzi, Lisa; Maggio, Ilaria; Campana, Davide